Pharmaceutical Drug Targets and Diseases
From Proteopedia
(Difference between revisions)
| Line 63: | Line 63: | ||
***[[Molecular_Playground/Taxol|Taxol Information]] | ***[[Molecular_Playground/Taxol|Taxol Information]] | ||
***[[Molecular_Playground/TRAIL|Tumor-Necrosis Factor Apoptosis-Inducing Ligand]] | ***[[Molecular_Playground/TRAIL|Tumor-Necrosis Factor Apoptosis-Inducing Ligand]] | ||
| - | |||
**Compromised Immune System | **Compromised Immune System | ||
| Line 69: | Line 68: | ||
**Diabetes & Hypoglycemia | **Diabetes & Hypoglycemia | ||
| + | ***[[Molecular_Playground/Insulin|Insulin Information]] | ||
***[[Peroxisome Proliferator-Activated Receptors]] | ***[[Peroxisome Proliferator-Activated Receptors]] | ||
Revision as of 10:41, 24 September 2010
The following is a list of major pharmaceutical compound targets, organized by disease.
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Alexander Berchansky, Eran Hodis, Thomas J. Stout, Wayne Decatur
